Of note, in COVID-19 patients with pneumonia, the ability of CD4+ T cells to produce IL-17 in vitro is increased, which can enhance inflammatory response and activate neutrophils, suggesting that T cell activation in COVID-19 patients is significantly biased toward Th-17 functional phenotype (De Biasi et al., 2020). This evidence concerns the gene IL17A and COVID-19.